Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 01:58:30 2026-01-16 am EST			5-day change	1st Jan Change
880.15 ^INR	-0.41%		-1.50%	-3.59%

Jan. 15	Agenus Falls After $141 Million Zydus Deal Closes	DJ
Jan. 15	Agenus Announces Closing of $141 Million Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness	CI

Press Releases

Jan. 14	Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO	AQ
Jan. 07	The 'Wow' Factor: Section 11 And the Jurisprudence of Trademark Confusion in Food Brands	AQ
Dec. 24	Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)	AQ
Dec. 23	Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®	AQ
25-08-20	Zydus Lifesciences : Press Release 20-08-2025 Newspaperadvertisement20082025	PU
25-08-13	Delhi High Court Denies Roche Access To Zydus' Confidential Information	AQ
25-08-05	Quia Timet Action Succeeds In Patent Dispute Over Biosimilar Of Nivolumab	AQ
25-07-17	Zydus Lifesciences : Press Release 17-07-2025 NewspaperpublicationAGMnotice17072025	PU
25-06-04	Zydus to enter global biologics CDMO business, Plans to acquire Agenus U.S. manufacturing facilities to accelerate development of innovative Therapies	AQ
25-05-08	Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes	BU
25-04-22	ITC Reversal Of Common ITC U/s17(2) Required In Relation To Activity Of Subscription And Redemption Of Mutual Funds	AQ
25-01-08	Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM andZituvimetTM XR to its template formulary	AQ
25-01-07	Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 Product Candidate for Treatment of Menkes Disease	AQ
24-09-02	Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days	AQ
24-08-15	Zynext Ventures Invests in neuro42, A Company Developing Portable MRI Systems for Neuroimaging and Interventions	AQ
24-06-18	Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems	AQ
24-05-06	Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals	AQ
24-04-22	Zydus launches Mirabegron Extended-Release Tablets in the US	BU
23-06-29	PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines	AQ
22-12-28	Zydus Lifesciences : Loss of Share Certificates	PU
22-10-18	Tetanus Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space \| DelveInsight	AQ
22-10-12	Hepatitis A Pipeline Landscape Analysis of 3+ Companies by DelveInsight	AQ
22-10-07	Zydus Lifesciences : General updates	PU
22-09-21	BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY for the Treatment of MoCD Type A	AQ
22-09-13	Zydus Lifesciences : receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Press Releases

Filters